US Pharma MarketingThe post Resmed sharpens sleep care focus with $490m software business sale appeared first on Medical Device Network.
Resmed sharpens sleep care focus with $490m software business sale
Resmed’s decision to sell MatrixCare to PE firm Frazier Healthcare Partners comes less than a decade after its $750m acquisition of the software business. Resmed’s decision to sell MatrixCare to PE firm Frazier Healthcare Partners comes less than a decade after its $750m acquisition of the software business. Resmed’s divestment of MatrixCare comes just one month after Resmed acquired Noctrix Health in a $340m deal to bolster its sleep care product portfolioCredit: JHVEPhoto/Shutterstock.com Resmed has agreed to sell its MatrixCare business in a $490m cash deal to PE firm Frazier Healthcare Partners, allowing it to dedicate its focus to its…
Resmed’s decision to sell MatrixCare to PE firm Frazier Healthcare Partners comes less than a decade after its $750m acquisition of the software business.
Source: Medical Device Network